PATS and ERS paediatric webinar: reducing the burden of CAP
A. Irungu (PATS, Nairobi, Kenya), Stefan Unger (Edinburgh, United Kingdom), A. Goga (Pretoria, South Africa), Massimiliano Don (Udine, Italy)
Thursday, 15 April 2021 |  |
Lung diseases and self-management – what is missing?
M. Clari (Torino, Italy), J. De Brandt (Diepenbeek, Belgium), C. Kelly (Lancashire, UK), K. Heslop-Marshall (Newcastle upon Tyne, UK), S. Jones (Cambridge, United Kingdom)
Tuesday, 13 April 2021 |  |
Congenital airway diseases
Eber (Graz, Austria), M. Schnater (Rotterdam, Netherlands), L. S. J. Kamphuis (Rotterdam, Netherlands), M. W.H. Pijnenburg (Rotterdam, Netherlands), C. Gotera (Madrid, Spain)
Tuesday, 23 March 2021 | |
ERS statement on chronic thromboembolic pulmonary hypertension
M. Delcroix (Leuven, Belgium), G. Simonneau (Le Kremlin-Bicêtre, France), E. Mayer (Bad Nauheim, Germany)
Thursday, 18 March 2021 | |
ERS short guidelines on COVID-19 management
N. Roche (Paris, France), J. Chalmers (Dundee, United Kingdom)
Thursday, 4 March 2021 | |
Wearable technologies in respiratory functional assessment
I. Vogiatzis (Newcastle upon Tyne, United Kingdom), A. Aliverti (Milan, Italy)
Thursday, 25 February 2021 |  |
Lung functional imaging
S. Bayat (Grenobe, France), G. Parraga (London (ON), Canada), J. M. Wild (Sheffield (South Yorkshire), United Kingdom)
Thursday, 11 February 2021 | |
ERS clinical practice guidelines on bronchiectasis in children
A. Chang (Australia), A. Kantar (Italy)
Tuesday, 2 February 2021 | |
Understanding new vaccines for SARS-CoV-2 and their regulation
A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom)
Monday, 1 February 2021 | |
ERS guideline on withdrawal of inhaled corticosteroids in COPD
J. Chalmers (Dundee, United Kingdom), M. Miravitlles (Barcelona, Spain)
Thursday, 21 January 2021 | |
IGRAs and other TB infection tests
D. Goletti (Rome, Italy), R. Duarte (Porto, Portugal)
Tuesday, 12 January 2021 | |